239241 While herbal medicines offer considerable therapeutic promise for GI disorders, their responsible use demands careful risk-benefit analysis, enhanced regulatory oversight, and increased clinician and patient awareness to optimize therapeutic outcomes and minimize harm
If the issue was genuine non-response to GLP-1 agonism, the dual mechanism of tirzepatide might provide the additional GIP-receptor activation needed for results
Int J Mol Sci (2017) 18(1):120
Ongoing clinical success, regulatory submissions, and backing by Eli Lilly further drive rapid market growth, making Orforglipron a leading therapy in both obesity management and type 2 diabetes treatment
Representative nanoengineering strategies include pH-responsive alginate coatings that co-encapsulate Escherichia coli Nissle 1917 (EcN) with 5-aminosalicylic acid, enabling simultaneous intestinal release of live bacteria and drug to modulate the microbiota, suppress pro-inflammatory cytokines, and repair the intestinal barrier (Peng et al., 2023)
BioMed Research International , 2015.PMID: 26236730 Comprehensive review of GHK-Cu's effects on skin remodeling including collagen synthesis, glycosaminoglycan production, and growth factor expression
